Literature DB >> 17683270

Severe malaria increases the list of heme oxygenase-1-protected diseases.

Ana Pamplona, Ian A Clark, Maria M Mota.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17683270     DOI： 10.2217/17460913.2.4.361

Source DB:  PubMed          Journal:  Future Microbiol        ISSN： 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  5 in total

1.  Histopathological studies in two strains of semi-immune mice infected with Plasmodium berghei ANKA after chronic exposure.

Authors:  Gideon Kofi Helegbe; Tetsuo Yanagi; Masachika Senba; Nguyen Tien Huy; Mohammed Nasir Shuaibu; Akiko Yamazaki; Mihoko Kikuchi; Michio Yasunami; Kenji Hirayama
Journal:  Parasitol Res       Date:  2010-10-27       Impact factor: 2.289

2.  Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.

Authors:  Miriam Canavese; Andrea Crisanti
Journal:  Pathog Glob Health       Date:  2015-09-21       Impact factor: 2.894

3.  VEGF promotes malaria-associated acute lung injury in mice.

Authors:  Sabrina Epiphanio; Marta G Campos; Ana Pamplona; Daniel Carapau; Ana C Pena; Ricardo Ataíde; Carla A A Monteiro; Nuno Félix; Artur Costa-Silva; Claudio R F Marinho; Sérgio Dias; Maria M Mota
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

4.  Interleukin-18 Antagonism Improved Histopathological Conditions of Malaria Infection in Mice.

Authors:  Marzieh Jabbarzare; Voon Kin Chin; Herni Talib; Mun Fei Yam; Siti Khadijah Adam; Haniza Hassan; Roslaini Abdul Majid; Che Norma Mat Taib; Mohamad Aris Mohd Moklas; Mohamad Taufik Hidayat; Hasidah Mohd Sidek; Rusliza Basir
Journal:  Iran J Parasitol       Date:  2015 Jul-Sep       Impact factor: 1.012

5.  Methaemoglobin and COHb in patients with malaria.

Authors:  Thomas Hänscheid; Tom Gresnigt; Sascha Löhr; Arnaud Flamen; Thomas Zoller; José Melo-Cristino; Martin P Grobusch
Journal:  Malar J       Date:  2014-07-23       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.